Current State of Human Gene Therapy: Approved Products and Vectors
In the realm of gene therapy, a pivotal moment arrived with Paul Berg’s groundbreaking identification of the first recombinant DNA in 1972. This achievement set the stage for future breakthroughs. Conditions once considered undefeatable, like melanoma, pancreatic cancer, and a host of other ailments...
Main Authors: | Aladdin Y. Shchaslyvyi, Svitlana V. Antonenko, Maksym G. Tesliuk, Gennadiy D. Telegeev |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/10/1416 |
Similar Items
-
Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review
by: Muhammad Hammad Butt, et al.
Published: (2022-07-01) -
Peptide-Based Vectors for Gene Delivery
by: Juan Yang, et al.
Published: (2023-08-01) -
Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
by: Oleg Mozhei, et al.
Published: (2020-12-01) -
How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
by: Myriam Sainz-Ramos, et al.
Published: (2021-07-01) -
Biomaterial‐based gene therapy
by: Yi Yu, et al.
Published: (2023-06-01)